EUVIMEDEUVIMED entdecken
Crossref

Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma

Wei-Feng Hong, Feng Zhang, Nan Wang, Jun-Ming Bi, Ding-Wen Zhang, Lu-Sheng Wei, Zhen-Tao Song, Gordon B Mills, Min-Min Chen, Xue-Xin Li, Shi-Suo Du, Min Yu

Drug Resistance Updates · 2024-09 · 76 · 101115

DOI: 10.1016/j.drup.2024.101115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-09. Verfasst von Wei-Feng Hong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreas Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Homologous Recombination, Macrophages, Pancreatic Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, notably resistant to existing therapies. Current research indicates that PDAC patients deficient in homologous recombination (HR) benefit from platinum-based treatments and poly-ADP-ribose polymerase inhibitors (PARPi). However, the effectiveness of PARPi in HR-deficient (HRD) PDAC is suboptimal, and significant challenges remain in fully understanding the distinct characteristics and implications of HRD-associated PDAC. We analyzed 16 PDAC patient-derived tissues, categorized by their homologous recombination deficiency (HRD) scores, and performed high-plex immunofluorescence analysis to define 20 cell phenotypes, thereby generating an in-situ PDAC tumor-immune landscape. Spatial phenotypic-transcriptomic profiling guided by regions-of-interest (ROIs) identified a crucial regulatory mechanism through localized tumor-adjacent macrophages, potentially in an HRD-dependent manner. Cellular neighborhood (CN) analysis further demonstrated the existence of macrophage-associated high-ordered cellular functional units in spatial contexts. Using our multi-omics spatial profiling strategy, we uncovered a dynamic macrophage-mediated regulatory axis linking HRD status with SIGLEC10 and CD52. These findings demonstrate the potential of targeting CD52 in combination with PARPi as a therapeutic intervention for PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalHomologous RecombinationMacrophagesPancreatic NeoplasmsHumansPoly(ADP-ribose) Polymerase InhibitorsTumor Microenvironment

Stichwörter der Autor:innen

Homologous recombination deficiencyMacrophagePancreatic ductal adenocarcinomaSpatial phenotypic-transcriptomic profilingTargeted therapy

Substanzen

Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Pancreas Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Department of Radiation Oncology, Zhejiang Cancer…
  • Department of Pancreas Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Cosmos Wisdom Biotech, co. ltd, Building 10, No. 617 Jiner Road, Hangzhou, Zhejiang, China.
  • Department of Urology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
  • Mills Institute for Personalized Cancer Care, Fynn Biotechnologies Ltd. Jinan, Shandong, China.
  • Division of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, USA.

Zitieren

APA

Hong, W. F., Zhang, F., Wang, N., Bi, J. M., Zhang, D. W., Wei, L. S., Song, Z. T., Mills, G. B., Chen, M. M., Li, X. X., Du, S. S., & Yu, M. (2024). Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Drug Resistance Updates, 76, 101115. https://doi.org/10.1016/j.drup.2024.101115

Vancouver

Hong WF, Zhang F, Wang N, Bi JM, Zhang DW, Wei LS, et al. Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Drug Resistance Updates. 2024;76:101115. doi:10.1016/j.drup.2024.101115

BibTeX
@article{Hong2024,
  author = {Hong, Wei-Feng and Zhang, Feng and Wang, Nan and Bi, Jun-Ming and Zhang, Ding-Wen and Wei, Lu-Sheng and Song, Zhen-Tao and Mills, Gordon B and Chen, Min-Min and Li, Xue-Xin and Du, Shi-Suo and Yu, Min},
  title = {Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {76},
  pages = {101115},
  doi = {10.1016/j.drup.2024.101115}
}
Kostenlos starten →